OCGN

Ocugen, Inc. OCGN

NasdaqSmall CapHealthcare

13F Pro quality score

Rank #2,473 of 2,925

Why it scores 30Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$1.49M

Quarter to Jun 30

Net income

$-24.88M

Quarter to Jun 30

Free cash flow

$-12.22M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$222.12M total
BlackRock, Inc.
$41.31M+269.7%
STATE STREET CORP
$32.85M+122.0%
VANGUARD CAPITAL MANAGEMENT LLC
$21.99M+4.1%
MILLENNIUM MANAGEMENT LLC
$21.33M+1.6%
GEODE CAPITAL MANAGEMENT, LLC
$13.58M+109.9%
RTW INVESTMENTS, LP
$10.20M0.0%
UBS Group AG
$7.92M-28.9%
Ikarian Capital, LLC
$6.06M0.0%
GMT CAPITAL CORP
$5.36M0.0%
MARSHALL WACE, LLP
$5.22M-57.6%
VANGUARD PORTFOLIO MANAGEMENT LLC
$5.09M+255.8%
Hennion & Walsh Asset Management, Inc.
$4.33M+121.7%
NORTHERN TRUST CORP
$4.20M+285.0%
VANGUARD FIDUCIARY TRUST CO
$3.62M+18.3%
TWO SIGMA INVESTMENTS, LP
$3.41M-0.9%
Qube Research & Technologies Ltd
$3.37M-41.6%
BANK OF AMERICA CORP /DE/
$3.05M+69.5%
HRT FINANCIAL LP
$2.71M+369.5%
BOOTHBAY FUND MANAGEMENT, LLC
$1.68M0.0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
$1.60M+391.5%
GOLDMAN SACHS GROUP INC
$1.56M-9.4%
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$1.56M+32.6%
Nuveen, LLC
$1.26MNew
Bank of New York Mellon Corp
$1.24M+839.2%
CITADEL ADVISORS LLC
$1.20M-72.1%
See all 148 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q2 2026
EDGAR

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Debt/Equity

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/OCGN

Earnings Per Share

13fpro.ai/company/OCGN

Loading ratio trend…

OCGN key financials by period

Reported revenue, net income and operating margin by fiscal year, from Ocugen, Inc.'s annual filings on SEC EDGAR.

Ocugen, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$4.4M$-67.8M—
FY 2024$4.1M$-54.1M—
FY 2023$6.0M$-63.1M—
FY 2022$2.5M$-86.8M—
FY 2020$43.0K$-21.8M—
Source: OCGN filings on SEC EDGAR →

OCGN insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

Congress trading in OCGN

2 transactions in OCGN reported by 1 member of Congress under the STOCK Act, most recent trade Nov 8, 2022. Reported transactions, not recommendations.

All Congress stock trades →

About Ocugen, Inc. (OCGN): stock profile, AI score and financials

Ocugen, Inc. (OCGN) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores OCGN at 30.2/100 on a composite quality score built from its SEC filings, placing it at rank #2,473 of 2,925 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), Ocugen, Inc. reports quarterly revenue of $1.5M, net income of $-24.9M, free cash flow of $-12.2M. Top institutional holders of OCGN by reported 13-F value include BlackRock, STATE STREET, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. OCGN trades on the Nasdaq exchange and files with the SEC under CIK 1372299. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate OCGN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Ocugen, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1372299 →